Bringing healthcare professionals the very latest clinical information and debate directly from the world’s leading experts.

PET tracers: Which, who and how? - Lyduine Collij
17:29
PET tracers: Which, who and how? - Lyduine Collij
Advances in AD PET biomarkers - Alexander Drzezga
25:25
Advances in AD PET biomarkers - Alexander Drzezga
Role of PET imaging in the disease modification era of Alzheimer's disease Silvia Morbelli
1:02:31
Role of PET imaging in the disease modification era of Alzheimer's disease Silvia Morbelli
Introduction - Frederik Barkhof
11:20
Introduction - Frederik Barkhof
CTAD – Breakfast Bite - Claire Paquet discusses the implications of the real-world
4:09
CTAD – Breakfast Bite - Claire Paquet discusses the implications of the real-world
CTAD – Juan Fortea comments on future opportunities for anti-amyloid antibody treatment
2:46
CTAD – Juan Fortea comments on future opportunities for anti-amyloid antibody treatment
Video shots | Highlights and latest updates from ESMO 2024
11:48
Video shots | Highlights and latest updates from ESMO 2024
Video shots | Highlights and latest content on ESMO 2024
12:44
Video shots | Highlights and latest content on ESMO 2024
Video shots | Highlights and updates from ESMO 2024
10:36
Video shots | Highlights and updates from ESMO 2024
Speed-meet the Multidisciplinary Team: Hematologist
11:38
Speed-meet the Multidisciplinary Team: Hematologist
Amyloidosis Center Success Story - Pavia, Italy
21:12
Amyloidosis Center Success Story - Pavia, Italy
Speed-meet the Multidisciplinary Team: Cardiologist
9:51
Speed-meet the Multidisciplinary Team: Cardiologist
Experts in Conversation: Highlights from AAIC
42:13
Experts in Conversation: Highlights from AAIC
CGM Updates and Highlights from EASD 2024
23:57
CGM Updates and Highlights from EASD 2024
Amyloidosis Centre Success Story
10:32
Amyloidosis Centre Success Story
Speed meet our multidisciplinary team - Christine Chiti
5:36
Speed meet our multidisciplinary team - Christine Chiti
ASCO24 Highlights: Advances in NSCLC
18:22
ASCO24 Highlights: Advances in NSCLC
AAIC – Is it too soon to use blood-based biomarkers for AD in primary care?
2:40
AAIC – Is it too soon to use blood-based biomarkers for AD in primary care?
AAIC - Discussing the potential for blood-based biomarker use
3:46
AAIC - Discussing the potential for blood-based biomarker use
Enhancing Diabetes Management:Clinician-Patient Collaboration on Continuous Glucose Monitoring (CGM)
25:43
Enhancing Diabetes Management:Clinician-Patient Collaboration on Continuous Glucose Monitoring (CGM)
ADPD 2024™: Earlier treatment with anti-amyloid immunotherapies - Podcast to Practice S1E2
4:03
ADPD 2024™: Earlier treatment with anti-amyloid immunotherapies - Podcast to Practice S1E2
CONY 2024: Sleep disturbance as a risk factor for Alzheimer's Disease - Podcast to Practice S1E3
5:06
CONY 2024: Sleep disturbance as a risk factor for Alzheimer's Disease - Podcast to Practice S1E3
CONY 2024: Comments on Lecanemab treatment extension beyond 18 months - Podcast to Practice S1E4
10:21
CONY 2024: Comments on Lecanemab treatment extension beyond 18 months - Podcast to Practice S1E4
Continuous Glucose Monitoring Updates and Highlights from ATTD 2024 - Podcast to Practice S3E1
25:25
Continuous Glucose Monitoring Updates and Highlights from ATTD 2024 - Podcast to Practice S3E1
Continuous Glucose Monitoring Updates and Highlights from ADA 2024 - Podcast to Practice S3E2
18:24
Continuous Glucose Monitoring Updates and Highlights from ADA 2024 - Podcast to Practice S3E2
Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1
9:48
Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1
AAIC Conference – Breakfast Bite 7 – The effects of time on blood-based biomarkers
1:48
AAIC Conference – Breakfast Bite 7 – The effects of time on blood-based biomarkers
Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSC...
6:28
Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSC...
Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in N...
7:18
Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in N...
Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond...
8:57
Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond...